Safety of trastuzumab in female patients with breast cancer: a retrospective cohort study
Latest Information Update: 14 Jul 2020
Price :
$35 *
At a glance
- Drugs Trastuzumab (Primary) ; Docetaxel; Paclitaxel; Pertuzumab
- Indications Breast cancer
- Focus Adverse reactions
- 14 Jul 2020 New trial record
- 01 Jul 2020 Results published in the Anticancer Research